-
Posted by
Two Blokes Jun 17 -
Filed in
Stock
-
7 views
HONG KONG--(BUSINESS WIRE)--Prime Success L.P., (together with its affiliates, “Prime Success” or “we”), a significant shareholder of Sinovac Biotech Ltd. (NASDAQ: SVA) (“Sinovac” or the “Company”) with ownership of approximately 8% of the Company's outstanding shares, today issued a statement in response to the Company's continued false, misleading and outright fabricated claims relating to the upcoming Special Meeting of Shareholders (the “Special Meeting”) scheduled for July 8, 2025. Prime S.
